TLXbenzinga

Telix Says FDA Approved New Drug Application For Gozellix, Its Next-Generation PSMA-PET Imaging Agent For Prostate Cancer

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on March 21, 2025 by benzinga

    Telix Says FDA Approved New Drug Application For Gozellix, Its Next-Generation PSMA-PET Imaging Agent For Prostate Cancer | TLX Stock News | Candlesense